Projects

Point of Care Technologies for Nutrition, Infection and Cancer for Global Health (PORTENT) Study (Evaluation and Validation of Point-of-Care Device Number 01 - Truenat® Malaria Pv-Pf (a new Q-PCR device for malaria testing by MolBio) over a 1-year period.)

Project Description

Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.

Project Duration

2024 - Ongoing

Project Lead

Dr. Mary Dias

Authors

Dr. Mary Dias

Project Status

completed

Project Type

NIH awarded to Cornell